These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29491159)

  • 21. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.
    Diao J; Pantua H; Ngu H; Komuves L; Diehl L; Schaefer G; Kapadia SB
    J Virol; 2012 Oct; 86(20):10935-49. PubMed ID: 22855500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
    Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
    J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
    So CW; Sourisseau M; Sarwar S; Evans MJ; Randall G
    PLoS Pathog; 2023 Dec; 19(12):e1011887. PubMed ID: 38157366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus receptor expression in normal and diseased liver tissue.
    Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
    Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Claudins and pathogenesis of viral infection.
    Tawar RG; Colpitts CC; Lupberger J; El-Saghire H; Zeisel MB; Baumert TF
    Semin Cell Dev Biol; 2015 Jun; 42():39-46. PubMed ID: 25960372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy.
    Cao L; Chen J; Wang Y; Yang Y; Qing J; Rao Z; Chen X; Lou Z
    Protein Cell; 2019 Mar; 10(3):178-195. PubMed ID: 29542010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
    Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
    PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells.
    Sung PS; Murayama A; Kang W; Kim MS; Yoon SK; Fukasawa M; Kondoh M; Kim JS; Kim H; Kato T; Shin EC
    J Virol; 2014 Aug; 88(16):9233-44. PubMed ID: 24899196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
    Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
    Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
    Haid S; Windisch MP; Bartenschlager R; Pietschmann T
    J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
    Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
    J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
    Padmanabhan P; Dixit NM
    PLoS One; 2012; 7(4):e36107. PubMed ID: 22545157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins.
    Hopcraft SE; Evans MJ
    Hepatology; 2015 Oct; 62(4):1059-69. PubMed ID: 25820616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus.
    Meertens L; Bertaux C; Cukierman L; Cormier E; Lavillette D; Cosset FL; Dragic T
    J Virol; 2008 Apr; 82(7):3555-60. PubMed ID: 18234789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection and tight junction proteins: The ties that bind.
    Mailly L; Baumert TF
    Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells.
    Clément CMH; Deffieu MS; Dorobantu CM; Baumert TF; Ayala-Nunez NV; Mély Y; Ronde P; Gaudin R
    Biol Cell; 2020 May; 112(5):140-151. PubMed ID: 32034780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COPII cargo claudin-12 promotes hepatitis C virus entry.
    Huang J; Yin P; Zhang L
    J Viral Hepat; 2019 Feb; 26(2):308-312. PubMed ID: 30339745
    [No Abstract]   [Full Text] [Related]  

  • 40. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
    Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
    J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.